ARTICLE | Company News
Sanomune, HealthPartners Research Foundation deal
March 9, 2009 7:00 AM UTC
The foundation granted Sanomune exclusive, worldwide rights to deferoxamine ( SAN-121), a nasally-delivered iron chelator in preclinical testing to treat Alzheimer's disease. Sanomune expects to begin...